Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells

Antitumor Responses Stimulated by Dendritic Cells Are Improved by Triiodothyronine Binding to the Thyroid Hormone Receptor β

Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm

Morphologic evidence of anti-tumor specificity of T cells activated by denritic cells derived from peripheral blood mononuclear cells of thyroid cancer patients

Advances in cellular therapy for the treatment of thyroid cancer

Beyond RET: potential therapeutic approaches for advanced and metastatic medullary thyroid carcinoma

Pilot trial of autologous dendritic cells loaded with tumor lysate(s) from allogeneic tumor cell lines in patients with metastatic medullary thyroid carcinoma

Dendritic cell vaccination with xenogenic polypeptide hormone induces tumor rejection in neuroendocrine cancer

Dendritic cell vaccination induces tumor epitope-specific Th1 immune response in medullary thyroid carcinoma

Results of a phase I clinical study using dendritic cell vaccinations for thyroid cancer